TR201903565T4 - Yara iyileşmesi için yöntemler ve bileşimler. - Google Patents

Yara iyileşmesi için yöntemler ve bileşimler. Download PDF

Info

Publication number
TR201903565T4
TR201903565T4 TR2019/03565T TR201903565T TR201903565T4 TR 201903565 T4 TR201903565 T4 TR 201903565T4 TR 2019/03565 T TR2019/03565 T TR 2019/03565T TR 201903565 T TR201903565 T TR 201903565T TR 201903565 T4 TR201903565 T4 TR 201903565T4
Authority
TR
Turkey
Prior art keywords
wound healing
methods
compositions
compounds
epoxy
Prior art date
Application number
TR2019/03565T
Other languages
English (en)
Inventor
Warren Reddell Paul
Anne Gordon Victoria
Moseley Ryan
Steadman Robert
Louise Moses Rachael
Mathew Boyle Glen
Gordon Parsons Peter
Original Assignee
Qbiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013901359A external-priority patent/AU2013901359A0/en
Application filed by Qbiotics Ltd filed Critical Qbiotics Ltd
Publication of TR201903565T4 publication Critical patent/TR201903565T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Abstract

Mevcut buluş, epoksi-tiglian bileşikleriyle ve bunların yara iyileşmesinin teşvik edilmesinde kullanımlarıyla ilgilidir. Belirli uygulamalarda epoksi-tiglian bileşikleri epoksi-tigliaen-3-on bileşikleridir. Yara iyileşmesini tetiklemeye veya teşvik etmeye yönelik yöntemlerin yanı sıra, bir yara iyileştikten sonra skarlaşmayı azaltmaya ve kozmetik neticeleri iyileştirmeye yönelik yöntemler de tarif edilmektedir. Ayrıca yara iyileşmesinde kullanıma yönelik bileşikler ve bileşimler de tarif edilmektedir.
TR2019/03565T 2013-04-18 2014-04-17 Yara iyileşmesi için yöntemler ve bileşimler. TR201903565T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2013901359A AU2013901359A0 (en) 2013-04-18 Methods of Treatment

Publications (1)

Publication Number Publication Date
TR201903565T4 true TR201903565T4 (tr) 2019-04-22

Family

ID=51730618

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/03565T TR201903565T4 (tr) 2013-04-18 2014-04-17 Yara iyileşmesi için yöntemler ve bileşimler.

Country Status (30)

Country Link
US (3) US10183921B2 (tr)
EP (1) EP2986615B1 (tr)
JP (1) JP6415538B2 (tr)
KR (1) KR102147796B1 (tr)
CN (1) CN105308052B (tr)
AU (1) AU2014253608B2 (tr)
BR (1) BR112015026388A8 (tr)
CA (1) CA2909653C (tr)
CY (1) CY1121515T1 (tr)
DK (1) DK2986615T3 (tr)
EA (1) EA032501B9 (tr)
ES (1) ES2715105T3 (tr)
HK (1) HK1214256A1 (tr)
HR (1) HRP20190435T1 (tr)
HU (1) HUE043272T2 (tr)
IL (1) IL242137B (tr)
LT (1) LT2986615T (tr)
MX (1) MX365255B (tr)
MY (1) MY184372A (tr)
NZ (1) NZ713954A (tr)
PH (1) PH12015502405A1 (tr)
PL (1) PL2986615T3 (tr)
PT (1) PT2986615T (tr)
RS (1) RS58532B1 (tr)
SG (1) SG11201508588XA (tr)
SI (1) SI2986615T1 (tr)
TR (1) TR201903565T4 (tr)
UA (1) UA118670C2 (tr)
WO (1) WO2014169356A1 (tr)
ZA (1) ZA201508186B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973858B2 (en) * 2016-02-12 2021-04-13 Laimu Corporation Nerve growth promoter and method for producing same, internal preparation, medium additive, cell dilution additive, medium, cell dilution, antioxidant and method for producing same, external preparation, and wound treatment agent and method for producing same
JP2019523303A (ja) * 2016-07-28 2019-08-22 キューバイオティクス リミティド 治療方法
EA201992220A1 (ru) 2017-03-23 2020-02-11 Кьюбиотикс Пти Лтд Комбинированная терапия для лечения или предупреждения опухолей
KR102249495B1 (ko) 2019-03-15 2021-06-01 주식회사 고위드 피부 관리 장치, 시스템 및 피부 관리 주기 결정 방법
CA3136216C (en) 2019-04-12 2024-01-16 QBiotics Pty Ltd Method of treating tumours
JP2022537367A (ja) * 2019-06-19 2022-08-25 キューバイオティクス プロプライアタリー リミティド バイオフィルムの破壊
CN112557541B (zh) * 2020-12-08 2022-07-12 河北科技大学 一种枸橼酸马罗匹坦及其有关物质的检测方法
WO2023115123A1 (en) * 2021-12-21 2023-06-29 QBiotics Pty Ltd Crystalline intermediates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
AU2001284364B2 (en) 2000-07-31 2006-09-28 Bar Ilan University Methods and pharmaceutical compositions for healing wounds
JP2005230051A (ja) * 2004-02-17 2005-09-02 Nippon Riko Igaku Kenkyusho:Kk 電位治療器
CA2578212A1 (en) * 2004-08-27 2006-03-09 Advanced Viral Research Corp. Methods for promoting wound healing
EP1971588B1 (en) * 2005-12-23 2012-07-11 QBiotics Limited Tiglien-3-one derivatives
JP4785062B2 (ja) 2007-03-20 2011-10-05 日精樹脂工業株式会社 スクリュ加熱回路を備えた射出装置
AU2010200429A1 (en) * 2009-02-05 2010-08-19 Ecobiotics Ltd Method of reducing or preventing blowfly strike
KR102030694B1 (ko) 2018-02-07 2019-11-18 엘지전자 주식회사 횡자속형 리니어 모터 및 이를 구비한 리니어 압축기

Also Published As

Publication number Publication date
MX365255B (es) 2019-05-28
WO2014169356A1 (en) 2014-10-23
US10183921B2 (en) 2019-01-22
AU2014253608A1 (en) 2015-11-26
EA032501B9 (ru) 2019-11-29
RS58532B1 (sr) 2019-04-30
US20190161462A1 (en) 2019-05-30
EA201591996A1 (ru) 2016-02-29
EA032501B1 (ru) 2019-06-28
HRP20190435T1 (hr) 2019-05-03
CN105308052B (zh) 2018-07-10
US10183922B2 (en) 2019-01-22
HUE043272T2 (hu) 2019-08-28
PH12015502405B1 (en) 2016-02-22
IL242137B (en) 2019-03-31
CA2909653C (en) 2022-04-12
LT2986615T (lt) 2019-03-25
CN105308052A (zh) 2016-02-03
JP6415538B2 (ja) 2018-10-31
US20160068499A1 (en) 2016-03-10
CY1121515T1 (el) 2020-05-29
US20170144981A1 (en) 2017-05-25
SG11201508588XA (en) 2015-11-27
KR102147796B1 (ko) 2020-08-26
EP2986615B1 (en) 2018-12-12
MX2015014607A (es) 2016-06-02
SI2986615T1 (sl) 2019-05-31
US10822317B2 (en) 2020-11-03
HK1214256A1 (zh) 2016-07-22
PT2986615T (pt) 2019-03-22
BR112015026388A2 (pt) 2017-07-25
ES2715105T3 (es) 2019-05-31
BR112015026388A8 (pt) 2019-12-31
DK2986615T3 (en) 2019-04-01
ZA201508186B (en) 2019-08-28
AU2014253608B2 (en) 2018-06-07
JP2016522801A (ja) 2016-08-04
KR20160023651A (ko) 2016-03-03
CA2909653A1 (en) 2014-10-23
PH12015502405A1 (en) 2016-02-22
EP2986615A4 (en) 2016-03-30
PL2986615T3 (pl) 2019-06-28
MY184372A (en) 2021-04-01
NZ713954A (en) 2020-05-29
EP2986615A1 (en) 2016-02-24
UA118670C2 (uk) 2019-02-25

Similar Documents

Publication Publication Date Title
TR201903565T4 (tr) Yara iyileşmesi için yöntemler ve bileşimler.
EA201690280A1 (ru) Композиции и способы, относящиеся к выделенным эндофитам
CY1121736T1 (el) Άλατα aramchol
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
BR112013032229A2 (pt) método de tratamento hidrocatalítico hidrotérmico de biomassa, e, composição
MX2016004678A (es) Composiciones para el tratamiento del cancer.
EA201591327A1 (ru) Замещенные пирролопиримидиновые соединения, их композиции и способы лечения с использованием таких соединений
EP2967076A4 (en) Compositions, methods and devices for promoting wound healing and reducing infection
EA201400748A1 (ru) Композиция для обработки семян
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
EA201201406A1 (ru) Фунгицидные смеси ii, содержащие хиназолины
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
ECSP14011792A (es) Inhibidores de iap
PH12016500497A1 (en) Compositions for the treatment of hypertension and/or fibrosis
BR112015027026A8 (pt) composição para uso na redução da formação de casca e na promoção da cicatrização
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
MX358132B (es) Solucion de trombina y metodos de uso de esta.
EA201591709A1 (ru) 5-бром-индирубины
EA201491581A1 (ru) Везикулярные композиции
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
BR112016014099A2 (pt) método de tratamento de feridas
EA201491455A1 (ru) ЭФФЕКТОРЫ β-АРРЕСТИНА, КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
EA201501177A1 (ru) Фармацевтические композиции
EA201492173A1 (ru) Дронедарон для применения при лейшманиозе, в составах и комбинациях для применения при лейшманиозе
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза